UniProt ID | AKT1_HUMAN | |
---|---|---|
UniProt AC | P31749 | |
Protein Name | RAC-alpha serine/threonine-protein kinase | |
Gene Name | AKT1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 480 | |
Subcellular Localization | Cytoplasm. Nucleus. Cell membrane. Nucleus after activation by integrin-linked protein kinase 1 (ILK1). Nuclear translocation is enhanced by interaction with TCL1A. Phosphorylation on Tyr-176 by TNK2 results in its localization to the cell membrane w | |
Protein Description | AKT1 is one of 3 closely related serine/threonine-protein kinases (AKT1, AKT2 and AKT3) called the AKT kinase, and which regulate many processes including metabolism, proliferation, cell survival, growth and angiogenesis. This is mediated through serine and/or threonine phosphorylation of a range of downstream substrates. Over 100 substrate candidates have been reported so far, but for most of them, no isoform specificity has been reported. AKT is responsible of the regulation of glucose uptake by mediating insulin-induced translocation of the SLC2A4/GLUT4 glucose transporter to the cell surface. Phosphorylation of PTPN1 at 'Ser-50' negatively modulates its phosphatase activity preventing dephosphorylation of the insulin receptor and the attenuation of insulin signaling. Phosphorylation of TBC1D4 triggers the binding of this effector to inhibitory 14-3-3 proteins, which is required for insulin-stimulated glucose transport. AKT regulates also the storage of glucose in the form of glycogen by phosphorylating GSK3A at 'Ser-21' and GSK3B at 'Ser-9', resulting in inhibition of its kinase activity. Phosphorylation of GSK3 isoforms by AKT is also thought to be one mechanism by which cell proliferation is driven. AKT regulates also cell survival via the phosphorylation of MAP3K5 (apoptosis signal-related kinase). Phosphorylation of 'Ser-83' decreases MAP3K5 kinase activity stimulated by oxidative stress and thereby prevents apoptosis. AKT mediates insulin-stimulated protein synthesis by phosphorylating TSC2 at 'Ser-939' and 'Thr-1462', thereby activating mTORC1 signaling and leading to both phosphorylation of 4E-BP1 and in activation of RPS6KB1. AKT is involved in the phosphorylation of members of the FOXO factors (Forkhead family of transcription factors), leading to binding of 14-3-3 proteins and cytoplasmic localization. In particular, FOXO1 is phosphorylated at 'Thr-24', 'Ser-256' and 'Ser-319'. FOXO3 and FOXO4 are phosphorylated on equivalent sites. AKT has an important role in the regulation of NF-kappa-B-dependent gene transcription and positively regulates the activity of CREB1 (cyclic AMP (cAMP)-response element binding protein). The phosphorylation of CREB1 induces the binding of accessory proteins that are necessary for the transcription of pro-survival genes such as BCL2 and MCL1. AKT phosphorylates 'Ser-454' on ATP citrate lyase (ACLY), thereby potentially regulating ACLY activity and fatty acid synthesis. Activates the 3B isoform of cyclic nucleotide phosphodiesterase (PDE3B) via phosphorylation of 'Ser-273', resulting in reduced cyclic AMP levels and inhibition of lipolysis. Phosphorylates PIKFYVE on 'Ser-318', which results in increased PI(3)P-5 activity. The Rho GTPase-activating protein DLC1 is another substrate and its phosphorylation is implicated in the regulation cell proliferation and cell growth. AKT plays a role as key modulator of the AKT-mTOR signaling pathway controlling the tempo of the process of newborn neurons integration during adult neurogenesis, including correct neuron positioning, dendritic development and synapse formation. Signals downstream of phosphatidylinositol 3-kinase (PI(3)K) to mediate the effects of various growth factors such as platelet-derived growth factor (PDGF), epidermal growth factor (EGF), insulin and insulin-like growth factor I (IGF-I). AKT mediates the antiapoptotic effects of IGF-I. Essential for the SPATA13-mediated regulation of cell migration and adhesion assembly and disassembly. May be involved in the regulation of the placental development. Phosphorylates STK4/MST1 at 'Thr-120' and 'Thr-387' leading to inhibition of its: kinase activity, nuclear translocation, autophosphorylation and ability to phosphorylate FOXO3. Phosphorylates STK3/MST2 at 'Thr-117' and 'Thr-384' leading to inhibition of its: cleavage, kinase activity, autophosphorylation at Thr-180, binding to RASSF1 and nuclear translocation. Phosphorylates SRPK2 and enhances its kinase activity towards SRSF2 and ACIN1 and promotes its nuclear translocation. Phosphorylates RAF1 at 'Ser-259' and negatively regulates its activity. Phosphorylation of BAD stimulates its pro-apoptotic activity. Phosphorylates KAT6A at 'Thr-369' and this phosphorylation inhibits the interaction of KAT6A with PML and negatively regulates its acetylation activity towards p53/TP53.; AKT1-specific substrates have been recently identified, including palladin (PALLD), which phosphorylation modulates cytoskeletal organization and cell motility; prohibitin (PHB), playing an important role in cell metabolism and proliferation; and CDKN1A, for which phosphorylation at 'Thr-145' induces its release from CDK2 and cytoplasmic relocalization. These recent findings indicate that the AKT1 isoform has a more specific role in cell motility and proliferation. Phosphorylates CLK2 thereby controlling cell survival to ionizing radiation.. | |
Protein Sequence | MSDVAIVKEGWLHKRGEYIKTWRPRYFLLKNDGTFIGYKERPQDVDQREAPLNNFSVAQCQLMKTERPRPNTFIIRCLQWTTVIERTFHVETPEEREEWTTAIQTVADGLKKQEEEEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDEEFTAQMITITPPDQDDSMECVDSERRPHFPQFSYSASGTA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Phosphorylation | ------MSDVAIVKE ------CCCEEEEEC | 40.57 | 101545721 | |
8 | Ubiquitination | MSDVAIVKEGWLHKR CCCEEEEECCCCCCC | 44.38 | 21890473 | |
8 | Ubiquitination | MSDVAIVKEGWLHKR CCCEEEEECCCCCCC | 44.38 | 21890473 | |
8 | Ubiquitination | MSDVAIVKEGWLHKR CCCEEEEECCCCCCC | 44.38 | 21890473 | |
14 | Methylation | VKEGWLHKRGEYIKT EECCCCCCCCCCCCC | 60.99 | 21775285 | |
14 | Acetylation | VKEGWLHKRGEYIKT EECCCCCCCCCCCCC | 60.99 | 21775285 | |
14 | Ubiquitination | VKEGWLHKRGEYIKT EECCCCCCCCCCCCC | 60.99 | 21775285 | |
20 | Acetylation | HKRGEYIKTWRPRYF CCCCCCCCCCCCEEE | 40.93 | 21775285 | |
20 | Ubiquitination | HKRGEYIKTWRPRYF CCCCCCCCCCCCEEE | 40.93 | 21775285 | |
30 | Ubiquitination | RPRYFLLKNDGTFIG CCEEEEECCCCCEEE | 55.96 | 21890473 | |
30 | Ubiquitination | RPRYFLLKNDGTFIG CCEEEEECCCCCEEE | 55.96 | 21890473 | |
30 | Ubiquitination | RPRYFLLKNDGTFIG CCEEEEECCCCCEEE | 55.96 | 21890473 | |
34 | Phosphorylation | FLLKNDGTFIGYKER EEECCCCCEEEEECC | 18.23 | 28857561 | |
39 | Ubiquitination | DGTFIGYKERPQDVD CCCEEEEECCCCCCC | 41.87 | - | |
65 | Phosphorylation | AQCQLMKTERPRPNT HHHHHHCCCCCCCCE | 24.22 | 46161783 | |
72 | Phosphorylation | TERPRPNTFIIRCLQ CCCCCCCEEEEEHHE | 20.92 | 22817900 | |
78 | Ubiquitination | NTFIIRCLQWTTVIE CEEEEEHHEEEEEEE | 3.23 | - | |
87 | Phosphorylation | WTTVIERTFHVETPE EEEEEEEEEECCCHH | 12.80 | 45553673 | |
92 | Phosphorylation | ERTFHVETPEEREEW EEEEECCCHHHHHHH | 34.61 | 45553679 | |
96 | Ubiquitination | HVETPEEREEWTTAI ECCCHHHHHHHHHHH | 45.53 | - | |
122 | Phosphorylation | EEEMDFRSGSPSDNS HHHCCCCCCCCCCCC | 43.55 | 29255136 | |
124 | Phosphorylation | EMDFRSGSPSDNSGA HCCCCCCCCCCCCCC | 23.60 | 29255136 | |
126 | O-linked_Glycosylation | DFRSGSPSDNSGAEE CCCCCCCCCCCCCCC | 51.63 | 22687243 | |
126 | Phosphorylation | DFRSGSPSDNSGAEE CCCCCCCCCCCCCCC | 51.63 | 29255136 | |
129 | O-linked_Glycosylation | SGSPSDNSGAEEMEV CCCCCCCCCCCCEEE | 44.35 | 22687243 | |
129 | Phosphorylation | SGSPSDNSGAEEMEV CCCCCCCCCCCCEEE | 44.35 | 25159151 | |
137 | Phosphorylation | GAEEMEVSLAKPKHR CCCCEEEECCCCCCE | 14.87 | 30266825 | |
140 | Ubiquitination | EMEVSLAKPKHRVTM CEEEECCCCCCEECH | 60.95 | - | |
146 | Phosphorylation | AKPKHRVTMNEFEYL CCCCCEECHHHHHHH | 17.78 | 7645411 | |
147 | Sulfoxidation | KPKHRVTMNEFEYLK CCCCEECHHHHHHHH | 4.07 | 30846556 | |
154 | Ubiquitination | MNEFEYLKLLGKGTF HHHHHHHHHHCCCCC | 40.54 | - | |
158 | Ubiquitination | EYLKLLGKGTFGKVI HHHHHHCCCCCCEEE | 55.54 | - | |
176 | Phosphorylation | EKATGRYYAMKILKK ECCCCCCCHHHHHCC | 10.00 | 20333297 | |
189 | Ubiquitination | KKEVIVAKDEVAHTL CCEEEEECHHHHHHH | 43.45 | - | |
206 | Ubiquitination | NRVLQNSRHPFLTAL CCCCCCCCCHHHHHH | 49.39 | - | |
211 | Phosphorylation | NSRHPFLTALKYSFQ CCCCHHHHHHHHHCC | 30.26 | 57413601 | |
214 | Ubiquitination | HPFLTALKYSFQTHD CHHHHHHHHHCCCCC | 36.06 | - | |
219 | Phosphorylation | ALKYSFQTHDRLCFV HHHHHCCCCCEEEEE | 24.59 | 24719451 | |
224 | S-nitrosylation | FQTHDRLCFVMEYAN CCCCCEEEEEEEECC | 2.23 | 22178444 | |
224 | S-nitrosocysteine | FQTHDRLCFVMEYAN CCCCCEEEEEEEECC | 2.23 | - | |
235 | Ubiquitination | EYANGGELFFHLSRE EECCCCEEEEEEEHH | 6.68 | - | |
239 | Ubiquitination | GGELFFHLSRERVFS CCEEEEEEEHHHCCC | 4.33 | - | |
246 | Phosphorylation | LSRERVFSEDRARFY EEHHHCCCHHHHHHH | 35.41 | 22817900 | |
268 | Ubiquitination | LDYLHSEKNVVYRDL HHHHHCCCCEECCCC | 59.04 | - | |
276 | Sumoylation | NVVYRDLKLENLMLD CEECCCCCHHHEEEC | 59.03 | - | |
276 | Ubiquitination | NVVYRDLKLENLMLD CEECCCCCHHHEEEC | 59.03 | 21890473 | |
276 | Sumoylation | NVVYRDLKLENLMLD CEECCCCCHHHEEEC | 59.03 | - | |
284 | Ubiquitination | LENLMLDKDGHIKIT HHHEEECCCCCEEEC | 62.74 | 22410793 | |
289 | Ubiquitination | LDKDGHIKITDFGLC ECCCCCEEECCCCCC | 33.60 | - | |
291 | Phosphorylation | KDGHIKITDFGLCKE CCCCEEECCCCCCCC | 21.92 | 57413599 | |
296 | S-nitrosocysteine | KITDFGLCKEGIKDG EECCCCCCCCCCCCC | 3.74 | - | |
296 | S-nitrosylation | KITDFGLCKEGIKDG EECCCCCCCCCCCCC | 3.74 | 22178444 | |
297 | Ubiquitination | ITDFGLCKEGIKDGA ECCCCCCCCCCCCCC | 65.11 | - | |
301 | Sumoylation | GLCKEGIKDGATMKT CCCCCCCCCCCCCCC | 62.05 | - | |
301 | Ubiquitination | GLCKEGIKDGATMKT CCCCCCCCCCCCCCC | 62.05 | - | |
301 | Sumoylation | GLCKEGIKDGATMKT CCCCCCCCCCCCCCC | 62.05 | - | |
305 | Phosphorylation | EGIKDGATMKTFCGT CCCCCCCCCCCCCCC | 25.40 | 22322096 | |
305 | O-linked_Glycosylation | EGIKDGATMKTFCGT CCCCCCCCCCCCCCC | 25.40 | 32830957 | |
308 | Dephosphorylation | KDGATMKTFCGTPEY CCCCCCCCCCCCHHH | 17.21 | 12637511 | |
308 | Phosphorylation | KDGATMKTFCGTPEY CCCCCCCCCCCCHHH | 17.21 | 22039466 | |
308 | O-linked_Glycosylation | KDGATMKTFCGTPEY CCCCCCCCCCCCHHH | 17.21 | 11278835 | |
310 | Glutathionylation | GATMKTFCGTPEYLA CCCCCCCCCCHHHHC | 7.79 | 22555962 | |
310 | S-nitrosylation | GATMKTFCGTPEYLA CCCCCCCCCCHHHHC | 7.79 | 22178444 | |
310 | S-nitrosocysteine | GATMKTFCGTPEYLA CCCCCCCCCCHHHHC | 7.79 | - | |
312 | Phosphorylation | TMKTFCGTPEYLAPE CCCCCCCCHHHHCHH | 17.71 | 22322096 | |
312 | O-linked_Glycosylation | TMKTFCGTPEYLAPE CCCCCCCCHHHHCHH | 17.71 | 32830957 | |
315 | Ubiquitination | TFCGTPEYLAPEVLE CCCCCHHHHCHHHHC | 14.90 | - | |
315 | Phosphorylation | TFCGTPEYLAPEVLE CCCCCHHHHCHHHHC | 14.90 | 22322096 | |
326 | Phosphorylation | EVLEDNDYGRAVDWW HHHCCCCCCCCHHHH | 18.11 | 142487 | |
338 | Ubiquitination | DWWGLGVVMYEMMCG HHHHHHHHHHHHHHC | 2.99 | - | |
377 | Ubiquitination | RTLGPEAKSLLSGLL CHHCHHHHHHHHHHC | 39.72 | 21890473 | |
378 | Phosphorylation | TLGPEAKSLLSGLLK HHCHHHHHHHHHHCC | 41.41 | 63776055 | |
381 | Phosphorylation | PEAKSLLSGLLKKDP HHHHHHHHHHCCCCH | 32.46 | 20873877 | |
396 | Phosphorylation | KQRLGGGSEDAKEIM HHCCCCCCHHHHHHH | 35.26 | 68699577 | |
400 | Ubiquitination | GGGSEDAKEIMQHRF CCCCHHHHHHHHHHH | 61.16 | - | |
417 | Phosphorylation | GIVWQHVYEKKLSPP HHHHHHHHHCCCCCC | 21.65 | 45553667 | |
420 | Acetylation | WQHVYEKKLSPPFKP HHHHHHCCCCCCCCC | 42.11 | 19817937 | |
422 | Phosphorylation | HVYEKKLSPPFKPQV HHHHCCCCCCCCCCC | 39.13 | 28348404 | |
426 | Ubiquitination | KKLSPPFKPQVTSET CCCCCCCCCCCCCCC | 40.07 | - | |
426 | Acetylation | KKLSPPFKPQVTSET CCCCCCCCCCCCCCC | 40.07 | 19817949 | |
430 | Phosphorylation | PPFKPQVTSETDTRY CCCCCCCCCCCCCCC | 18.65 | 30624053 | |
431 | Phosphorylation | PFKPQVTSETDTRYF CCCCCCCCCCCCCCC | 39.37 | 26657352 | |
435 | Phosphorylation | QVTSETDTRYFDEEF CCCCCCCCCCCCHHC | 34.39 | - | |
437 | Phosphorylation | TSETDTRYFDEEFTA CCCCCCCCCCHHCEE | 19.92 | 22817900 | |
443 | Phosphorylation | RYFDEEFTAQMITIT CCCCHHCEEEEEEEC | 21.18 | 69006271 | |
448 | Phosphorylation | EFTAQMITITPPDQD HCEEEEEEECCCCCC | 17.29 | 26657352 | |
450 | Phosphorylation | TAQMITITPPDQDDS EEEEEEECCCCCCCC | 21.81 | 21464307 | |
457 | Phosphorylation | TPPDQDDSMECVDSE CCCCCCCCCCCCCCC | 25.44 | 68996393 | |
473 | Phosphorylation | RPHFPQFSYSASGTA CCCCCCCCCCCCCCC | 16.96 | 15855334 | |
473 | O-linked_Glycosylation | RPHFPQFSYSASGTA CCCCCCCCCCCCCCC | 16.96 | 11313365 | |
473 | Dephosphorylation | RPHFPQFSYSASGTA CCCCCCCCCCCCCCC | 16.96 | 12637511 | |
474 | Phosphorylation | PHFPQFSYSASGTA- CCCCCCCCCCCCCC- | 15.00 | 22322096 | |
475 | Phosphorylation | HFPQFSYSASGTA-- CCCCCCCCCCCCC-- | 18.11 | 22322096 | |
477 | Phosphorylation | PQFSYSASGTA---- CCCCCCCCCCC---- | 30.64 | 22322096 | |
479 | Phosphorylation | FSYSASGTA------ CCCCCCCCC------ | 27.05 | 22322096 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
72 | T | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
129 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
176 | Y | Phosphorylation | Kinase | TNK2 | Q07912 | Uniprot |
246 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
308 | T | Phosphorylation | Kinase | AXL | P30530 | PSP |
308 | T | Phosphorylation | Kinase | TYRO3 | Q06418 | PSP |
308 | T | Phosphorylation | Kinase | TBK1 | Q9UHD2 | Uniprot |
308 | T | Phosphorylation | Kinase | PIK3CA | P42336 | PSP |
308 | T | Phosphorylation | Kinase | PDK1 | O15530 | PSP |
308 | T | Phosphorylation | Kinase | PDK1 | Q15118 | GPS |
308 | T | Phosphorylation | Kinase | MERTK | Q12866 | GPS |
308 | T | Phosphorylation | Kinase | PRKD1 | Q15139 | PSP |
308 | T | Phosphorylation | Kinase | PRKCB | P05771 | GPS |
308 | T | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
308 | T | Phosphorylation | Kinase | CAMKK2 | Q96RR4 | PSP |
308 | T | Phosphorylation | Kinase | IKBKE | Q14164 | GPS |
312 | T | Phosphorylation | Kinase | GSK3A | P49840 | PSP |
315 | Y | Phosphorylation | Kinase | RET | P07949 | PSP |
315 | Y | Phosphorylation | Kinase | PTK6 | Q13882 | GPS |
326 | Y | Phosphorylation | Kinase | PTK6 | Q13882 | GPS |
450 | T | Phosphorylation | Kinase | MTOR | P42345 | PSP |
473 | S | Phosphorylation | Kinase | IKBKE | Q14164 | GPS |
473 | S | Phosphorylation | Kinase | AXL | P30530 | PSP |
473 | S | Phosphorylation | Kinase | TBK1 | Q9UHD2 | Uniprot |
473 | S | Phosphorylation | Kinase | PIKFYVE | Q9Y2I7 | PSP |
473 | S | Phosphorylation | Kinase | PRKDC | P78527 | GPS |
473 | S | Phosphorylation | Kinase | PDPK1 | O15530 | PhosphoELM |
473 | S | Phosphorylation | Kinase | PDK1 | Q15118 | GPS |
473 | S | Phosphorylation | Kinase | PRKCA | P17252 | GPS |
473 | S | Phosphorylation | Kinase | PIK3R1 | P27986 | PSP |
473 | S | Phosphorylation | Kinase | MTOR | Q9JLN9 | PSP |
473 | S | Phosphorylation | Kinase | MTOR | P42345 | Uniprot |
473 | S | Phosphorylation | Kinase | MERTK | Q12866 | GPS |
473 | S | Phosphorylation | Kinase | ILK | Q13418 | PSP |
473 | S | Phosphorylation | Kinase | MAPKAPK2 | P49137 | PSP |
473 | S | Phosphorylation | Kinase | LRRK2 | Q5S007 | PSP |
473 | S | Phosphorylation | Kinase | PRKD1 | Q15139 | PSP |
473 | S | Phosphorylation | Kinase | PRKCB | P05771 | GPS |
477 | S | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
479 | T | Phosphorylation | Kinase | CDK2 | P24941 | PSP |
- | K | Ubiquitination | E3 ubiquitin ligase | BRCA1 | P38398 | PMID:19074868 |
- | K | Ubiquitination | E3 ubiquitin ligase | TRIM13 | O60858 | PMID:21333377 |
- | K | Ubiquitination | E3 ubiquitin ligase | MUL1 | Q969V5 | PMID:22410793 |
- | K | Ubiquitination | E3 ubiquitin ligase | NEDD4 | P46934 | PMID:23195959 |
- | K | Ubiquitination | E3 ubiquitin ligase | SKP2 | Q13309 | PMID:24658274 |
- | K | Ubiquitination | E3 ubiquitin ligase | TTC3 | P53804 | PMID:20059950 |
- | K | Ubiquitination | E3 ubiquitin ligase | TRAF6 | Q9Y4K3 | PMID:22199232 |
- | K | Ubiquitination | E3 ubiquitin ligase | STUB1 | Q9UNE7 | PMID:18292230 |
- | K | Ubiquitination | E3 ubiquitin ligase | ZNRF1 | Q8ND25 | PMID:14561866 |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
14 | K | Acetylation |
| 19713527 |
14 | K | Acetylation |
| 19713527 |
20 | K | Acetylation |
| 21775285 |
20 | K | Acetylation |
| 21775285 |
48 | K | ubiquitylation |
| 19713527 |
48 | K | Phosphorylation |
| 19713527 |
48 | K | ubiquitylation |
| 19713527 |
284 | K | ubiquitylation |
| 22410793 |
284 | K | Phosphorylation |
| 22410793 |
305 | T | Phosphorylation |
| 22629392 |
308 | T | Phosphorylation |
| 8978681 |
308 | T | Phosphorylation |
| 8978681 |
308 | T | Phosphorylation |
| 8978681 |
308 | T | Phosphorylation |
| 8978681 |
308 | T | Phosphorylation |
| 8978681 |
308 | T | Phosphorylation |
| 8978681 |
312 | T | Phosphorylation |
| 22629392 |
473 | S | Phosphorylation |
| 9736715 |
473 | S | Phosphorylation |
| 9736715 |
473 | S | Phosphorylation |
| 9736715 |
473 | S | Phosphorylation |
| 9736715 |
473 | S | Phosphorylation |
| 9736715 |
473 | S | Phosphorylation |
| 9736715 |
473 | S | Phosphorylation |
| 9736715 |
473 | S | Phosphorylation |
| 9736715 |
473 | S | Phosphorylation |
| 9736715 |
473 | S | Phosphorylation |
| 9736715 |
473 | S | Phosphorylation |
| 9736715 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AKT1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00539 | PTEN hamartoma tumor syndrome (PHTS), including: Cowden syndrome; Bannayan-Riley-Ruvalcaba syndrome; | |||||
OMIM Disease | ||||||
114480 | Breast cancer (BC) | |||||
114500 | Colorectal cancer (CRC) | |||||
Note=Genetic variations in AKT1 may play a role in susceptibility to ovarian cancer. | ||||||
176920 | ||||||
615109 | Cowden syndrome 6 (CWS6) | |||||
Kegg Drug | ||||||
D10381 | Afuresertib (USAN) | |||||
D10382 | Afuresertib hydrochloride (USAN) | |||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"The deacetylase SIRT1 promotes membrane localization and activationof Akt and PDK1 during tumorigenesis and cardiac hypertrophy."; Sundaresan N.R., Pillai V.B., Wolfgeher D., Samant S., Vasudevan P.,Parekh V., Raghuraman H., Cunningham J.M., Gupta M., Gupta M.P.; Sci. Signal. 4:RA46-RA46(2011). Cited for: INTERACTION WITH SIRT1, ACETYLATION AT LYS-14 AND LYS-20,DEACETYLATION AT LYS-14 AND LYS-20, AND MUTAGENESIS OF LYS-14; GLU-17AND LYS-20. | |
O-linked Glycosylation | |
Reference | PubMed |
"Extensive crosstalk between O-GlcNAcylation and phosphorylationregulates Akt signaling."; Wang S., Huang X., Sun D., Xin X., Pan Q., Peng S., Liang Z., Luo C.,Yang Y., Jiang H., Huang M., Chai W., Ding J., Geng M.; PLoS ONE 7:E37427-E37427(2012). Cited for: GLYCOSYLATION AT SER-126; SER-129; THR-305 AND THR-312. | |
Phosphorylation | |
Reference | PubMed |
"Ack1 mediated AKT/PKB tyrosine 176 phosphorylation regulates itsactivation."; Mahajan K., Coppola D., Challa S., Fang B., Chen Y.A., Zhu W.,Lopez A.S., Koomen J., Engelman R.W., Rivera C., Muraoka-Cook R.S.,Cheng J.Q., Schoenbrunn E., Sebti S.M., Earp H.S., Mahajan N.P.; PLoS ONE 5:E9646-E9646(2010). Cited for: FUNCTION, SUBCELLULAR LOCATION, PHOSPHORYLATION AT TYR-176; THR-308AND SER-473, MUTAGENESIS OF TYR-176, INTERACTION WITH TNK2, AND TISSUESPECIFICITY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124; SER-126 ANDSER-129, AND MASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-124; SER-126 ANDSER-129, AND MASS SPECTROMETRY. | |
"Activation of Akt independent of PTEN and CTMP tumor-suppressor genemutations in epilepsy-associated Taylor-type focal corticaldysplasias."; Schick V., Majores M., Engels G., Spitoni S., Koch A., Elger C.E.,Simon M., Knobbe C., Bluemcke I., Becker A.J.; Acta Neuropathol. 112:715-725(2006). Cited for: PHOSPHORYLATION AT SER-473. | |
"Phosphorylation and regulation of Akt/PKB by the rictor-mTORcomplex."; Sarbassov D.D., Guertin D.A., Ali S.M., Sabatini D.M.; Science 307:1098-1101(2005). Cited for: PHOSPHORYLATION AT THR-308, AND PHOSPHORYLATION AT SER-473 BY MTOR. | |
"LGI1, a putative tumor metastasis suppressor gene, controls in vitroinvasiveness and expression of matrix metalloproteinases in gliomacells through the ERK1/2 pathway."; Kunapuli P., Kasyapa C.S., Hawthorn L., Cowell J.K.; J. Biol. Chem. 279:23151-23157(2004). Cited for: PHOSPHORYLATION AT SER-473. | |
"PIKE (phosphatidylinositol 3-kinase enhancer)-A GTPase stimulates Aktactivity and mediates cellular invasion."; Ahn J.-Y., Rong R., Kroll T.G., Van Meir E.G., Snyder S.H., Ye K.; J. Biol. Chem. 279:16441-16451(2004). Cited for: INTERACTION WITH AGAP2, AND PHOSPHORYLATION AT SER-473. | |
"Mechanism of activation of protein kinase B by insulin and IGF-1."; Alessi D.R., Andjelkovic M., Caudwell F.B., Cron P., Morrice N.,Cohen P., Hemmings B.A.; EMBO J. 15:6541-6551(1996). Cited for: MUTAGENESIS OF THR-308 AND SER-473, AND PHOSPHORYLATION AT THR-308 ANDSER-473. | |
"Phosphoinositide-3-OH kinase-dependent regulation of glycogensynthase kinase 3 and protein kinase B/AKT by the integrin-linkedkinase."; Delcommenne M., Tan C., Gray V., Rue L., Woodgett J.R., Dedhar S.; Proc. Natl. Acad. Sci. U.S.A. 95:11211-11216(1998). Cited for: ENZYME REGULATION, AND PHOSPHORYLATION AT SER-473. | |
"Design of selective, ATP-competitive inhibitors of Akt."; Freeman-Cook K.D., Autry C., Borzillo G., Gordon D.,Barbacci-Tobin E., Bernardo V., Briere D., Clark T., Corbett M.,Jakubczak J., Kakar S., Knauth E., Lippa B., Luzzio M.J., Mansour M.,Martinelli G., Marx M., Nelson K., Pandit J., Rajamohan F.,Robinson S., Subramanyam C., Wei L., Wythes M., Morris J.; J. Med. Chem. 53:4615-4622(2010). Cited for: X-RAY CRYSTALLOGRAPHY (2.01 ANGSTROMS) OF 144-480, PHOSPHORYLATION ATTHR-308, AND ENZYME REGULATION. | |
"Synthesis and structure based optimization of novel Akt inhibitors."; Lippa B., Pan G., Corbett M., Li C., Kauffman G.S., Pandit J.,Robinson S., Wei L., Kozina E., Marr E.S., Borzillo G., Knauth E.,Barbacci-Tobin E.G., Vincent P., Troutman M., Baker D., Rajamohan F.,Kakar S., Clark T., Morris J.; Bioorg. Med. Chem. Lett. 18:3359-3363(2008). Cited for: X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 144-480, PHOSPHORYLATION ATTHR-308, AND ENZYME REGULATION. | |
"Activation of protein kinase B beta and gamma isoforms by insulin invivo and by 3-phosphoinositide-dependent protein kinase-1 in vitro:comparison with protein kinase B alpha."; Walker K.S., Deak M., Paterson A., Hudson K., Cohen P., Alessi D.R.; Biochem. J. 331:299-308(1998). Cited for: FUNCTION, ENZYME REGULATION, AND PHOSPHORYLATION AT THR-308 BY PDPK1. | |
"Direct identification of tyrosine 474 as a regulatory phosphorylationsite for the Akt protein kinase."; Conus N.M., Hannan K.M., Cristiano B.E., Hemmings B.A., Pearson R.B.; J. Biol. Chem. 277:38021-38028(2002). Cited for: PHOSPHORYLATION AT TYR-474, AND MUTAGENESIS OF TYR-474. |